Sling vs No Sling After Reverse Total Shoulder Arthroplasty
Launched by DUKE UNIVERSITY · Oct 16, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of using a sling after a reverse total shoulder replacement surgery. Patients who are scheduled to have this surgery at Duke University will be randomly placed into two groups: one group will wear a sling for three weeks after surgery, while the other group will only wear a sling for three days. The goal is to see how these different approaches impact recovery and shoulder function.
To participate in this study, you need to be between 18 and 100 years old, scheduled for the surgery, and able to communicate in English. You'll also need to commit to follow-up appointments at 2 weeks, 6 weeks, 3 months, 6 months, 1 year, and 2 years after your surgery. It's important to note that certain medical histories, such as previous shoulder surgeries or specific shoulder conditions, may exclude you from participating. If you're eligible and choose to join, you'll help researchers learn more about the best ways to support recovery after shoulder surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient is scheduled to undergo a primary reverse shoulder arthroplasty procedure
- • Patient voluntarily consents to participate in the study and has the mental and physical ability to participate in the study, fill out subjective questionnaires, return for follow-up visits, and comply with prescribed post-operative physical therapy
- • Patient meets indications for primary reverse shoulder arthroplasty for the following diagnosis
- • Rotator cuff arthropathy
- • Glenohumeral arthritis
- • Patient is between 18-100 years old
- • Patient is English speaking
- Exclusion Criteria:
- • A history of ipsilateral shoulder arthroplasty
- • A history of shoulder septic arthritis
- • A history of a proximal humeral fracture
- • Chronic locked dislocation
- • Rheumatoid arthritis
- • Tumors
- • Axillary nerve damage
- • Non-functioning deltoid muscle
- • Glenoid vault deficiency precluding baseplate fixation
- • Infection and neuropathic joints
- • Known or suspected non-compliance, drug or alcohol abuse
- • Patients incapable of judgement or under tutelage
- • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, contraindication for imaging etc.
- • The subject is related to investigator as family members, employees, or other dependent persons
About Duke University
Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Durham, North Carolina, United States
Durham, North Carolina, United States
Patients applied
Trial Officials
Oke A Anakwenze, MD, MBA
Principal Investigator
Duke University
Christopher Klifto, MD
Principal Investigator
Duke University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported